(Q34275294)

1 August 2017

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter (English)

1 reference

1 August 2017

1 reference

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

30 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

30 March 2024

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

30 March 2024

1

David Dingli

1 reference

1 August 2017

6

Roberto Cattaneo

1 reference

1 August 2017

8

Stephen J Russell

1 reference

1 August 2017

2

Kah-Whye Peng

1 reference

1 August 2017

4

Philip R Greipp

1 reference

1 August 2017

Mary E. Harvey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604966

30 March 2024

Michael K. O'Connor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604966

30 March 2024

John C. Morris

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604966

30 March 2024

language of work or name

English

0 references

publication date

6 November 2003

1 reference

1 August 2017

1 reference

1 August 2017

103

1 reference

1 August 2017

1641-1646

1 reference

1 August 2017

5

1 reference

1 August 2017

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Current therapy for multiple myeloma

30 March 2024

3

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Novel therapies targeting the myeloma cell and its bone marrow microenvironment

30 March 2024

5

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergrou

30 March 2024

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Strontium-89: a novel treatment for a case of osteosclerotic myeloma associated with life-threatening neuropathy

30 March 2024

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

The emerging fields of suicide gene therapy and virotherapy.

30 March 2024

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Measles virus interactions with cellular receptors: consequences for viral pathogenesis

30 March 2024

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice

30 March 2024

12

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Systemic therapy of myeloma xenografts by an attenuated measles virus

30 March 2024

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

30 March 2024

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer

30 March 2024

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas

30 March 2024

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

EGS4 Monte Carlo determination of the beta dose kernel in water

30 March 2024

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Genetically targeted radiotherapy for multiple myeloma

30 March 2024

22

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Iodide transport in a continuous line of cultured cells from rat thyroid

30 March 2024

24

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

In vivo sodium iodide symporter gene therapy of prostate cancer

30 March 2024

25

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

RNA viruses as virotherapy agents

30 March 2024

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider

30 March 2024

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Regression of Hodgkin's disease after measles

30 March 2024

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Successes and failures in measles control

30 March 2024

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Imaging of myeloma bone disease--implications for staging, prognosis and follow-up

30 March 2024

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Angiogenesis in multiple myeloma

30 March 2024

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Efficiency of measles virus entry and dissemination through different receptors

30 March 2024

35

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

30 March 2024

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

A possible role of CD46 for the protection in vivo of human renal tumor cells from complement-mediated damage

30 March 2024

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.

30 March 2024

38

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.

30 March 2024

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2233

30 March 2024

Identifiers

1 reference

1 August 2017

1 reference